Has Keith Mortman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $170,213 in general payments to Keith Mortman, MD across 211 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Keith Mortman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Keith Mortman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Keith Mortman, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Washington, DCNPI 1245336965

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $141,747 of the $170,213 with a category attached, or 83.3%. Medical Device Business Services, Inc. accounts for 67.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $62,729 and has fallen 95.0% since, to $3,128 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$170,213in general payments, 2019–2025

Across 211 payments — averaging $806.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$114K
Johnson & Johnson$34K
Davol Inc.$13K
Covidien LP$3K
Intuitive Surgical$2K
Surgical Theater. Inc.$1K
plus $2K from 9 others

$92,259in research payments, 2019–2025

Across 18 payments — averaging $5125.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Ethicon Endo-surgery Inc.$91K
Covidien LP$2K

What the payments were for

Consulting fees$141,74783%
Speaking & faculty fees$3,8252%
Travel & lodging$13,3198%
Food & beverage$10,3236%
Education$1,0001%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	81	$114,078
Johnson & Johnson(2 entities)	56	$34,032
Davol Inc.	31	$13,168
Covidien LP	6	$3,266
Intuitive Surgical	12	$2,290
Surgical Theater. Inc.	2	$1,039
AstraZeneca	8	$967
GSK	3	$391
Sanofi	2	$238
BD	3	$189
Grifols USA, LLC	1	$133
Amgen	1	$118
Insmed, Inc.	1	$117
Boehringer Ingelheim	1	$115
Medtronic	3	$73

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$170,213 in reported general payments places this provider in the 95th percentile of 25 thoracic surgery (cardiothoracic vascular surgery) providers in District of Columbia.

See all thoracic surgery (cardiothoracic vascular surgery) providers in District of Columbia →

Medicare billing

Part B allowed, 2024

$58,460

Medicare patients

128

Services billed

284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Washington

John LazarWashington$79K
Salim AzizWashington$24K
Gal LevyWashington$23K
Farzad NajamWashington$19K
Steven BoyceWashington$13K
Jeffrey CohenWashington$11K
Gregory TrachiotisWashington$10K
Deyanira PrasteinWashington$6K
Sora ElyWashington$5K
Dean SchraufnagelWashington$4K

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →